Evaluation of ts and enosf1 variants process: submission:02/21/2022 acceptance:08/25/2022 evaluation of ts and enosf1 variants as biomarker in response to neoadjuvant chemotherapy based on 5fu in gastric patients

HIGHLIGHTS

• who: Asian Pac J Cancer and collaborators from the Patients Between , and, formalin-fixed paraffinembedded (FFPE) tissues with gastric cancer were recruited from the Cancer Institute of Imam Khomeini Hospital in Tehran, IranPrior to gastrectomy, all patients received neoadjuvant chemotherapy with FU. The response to FU treatment was evaluated using the most recent protocol for examining specimens from patients with stomach carcinoma (Shi et_al, ). Tehran Azad University of Science and Research`s Medical have published the research: Evaluation of TS and ENOSF1 Variants Process: Submission:02/21/2022 Acceptance:08/25/2022 Evaluation of TS and ENOSF1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.